Site Search

Share

X

Search Results

Health Equity in Biomarker Testing and Targeted Therapy

Despite evidence demonstrating the effectiveness of biomarker testing and targeted therapy, currently not all individuals benefit equitably from these advances. There are notable racial/ethnic, and ... socioeconomic disparities in access and utilization of these advancements in care. These disparities in access and use of guideline-indicated biomarker testing and targeted therapy can potentially widen existing disparities in cancer survival. Health Equity in Biomarker Testing and ...

Hawaii Cancer Advocates Celebrate Passage of Biomarker Testing Resolution

... of HCR 53 during the 2024 legislative session. The resolution moves Hawaii one step closer to advancing legislation to expand access to the testing needed to connect cancer patients and those battling other diseases to precision treatments through biomarker testing . The decision by state legislators coincides with the May 1st release of the American Cancer Society’s first-ever Cancer Facts ... limited, the study can help raise awareness of symptoms and opportunities for prevention, early detection, and treatment.  Increasing access to biomarker testing for Hawaii residents could be a game-changer in connecting cancer patients with the right treatment needed to battle their ...

Payer Coverage Policies of Tumor Biomarker and Pharmacogenomic Testing

Biomarker testing is key to unlocking precision medicine and improving cancer outcomes, however not all individuals are benefiting. In a survey of over 300 oncology providers, 66% reported that insurance coverage for biomarker testing is a moderate or significant barrier to appropriate testing for their patients. Additionally, 91% indicated that they consult clinical ...

Marylanders to Gain Access to Biomarker Testing on Jan. 1

ANNAPOLIS, MD – DECEMBER 20, 2023 – On January 1, 2024, Marylanders will gain access to biomarker testing when Chapter 322 of the Laws of 2023 takes effect for private insurers. The legislation, which requires coverage of biomarker testing when supported by scientific and medical evidence, received near-unanimous support in the Senate and House of Delegates. Governor ...

Connecticut House Votes to Improve Access to Biomarker Testing

HARTFORD – May 9, 2025 – Yesterday, the Connecticut House voted in unanimous support of legislation that would ensure biomarker testing is covered by state regulated insurance plans, including Medicaid, when supported by scientific and medical evidence. The goal of the ... a statement from Bryte Johnson, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Connecticut: “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but ...

Maryland Lawmakers Overwhelmingly Support Increasing Access to Biomarker Testing

... passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered by all state-regulated health plans, including Medicaid, when it is supported by medical and scientific evidence. With the Governor’s signature, more Marylanders will benefit from biomarker testing, a critical step in accessing precision medicine services. Dubbed ‘the right treatment at the right time,’ precision medicine ...

The Landscape of Biomarker Testing Coverage in the U.S.

Biomarker testing is becoming increasingly important for cancer care because it connects the right patient, to the right treatment, at the right time, however insurance coverage of testing varies widely. This study, that examines administrative claims data to understand the premium impact of expanding biomarker testing coverage in four markets: commercial self-insured large group, small group, individual, and Medicaid, found a small potential ...

Mississippi House Passes 'Jill's Law' for Biomarker Testing Coverage

JACKSON, Miss. –  The Mississippi House passed House Bill 565 Wednesday, paving the way for increased access to biomarker testing for patients across the Magnolia State. Biomarker testing is a key tool used by physicians to identify the most effective treatments for cancer and other diseases. “In the case of a ...

Share Your Story About Precision Medicine and Biomarker Testing

Share Your Story About Precision Medicine and Biomarker Testing ...

State Policy Principles to Support Access to Biomarker Testing

...                                                                                               Biomarker testing is available for an ever-increasing range of conditions and diseases. Data shows that patients receiving targeted treatments, also known as ... – a roadmap for working with state policymakers to advance solutions that reduce barriers to access and promote patient outcomes.  What is Biomarker Testing? Biomarkers are an essential part of precision medicine providing necessary information for appropriate therapeutic intervention. ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy